|
Market Closed -
Nasdaq Stockholm
17:00:00 26/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.930 SEK | -2.53% |
|
+1.05% | +1.58% |
| 10-21 | Enzymatica AB Signs Distribution Agreement With MedonyX For ColdZyme In Jordan And Iraq | CI |
| 10-16 | STADA Launches Virustad In Germany Based On Enzymatica's ColdZyme Technology | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENZYMATICA AB | Other Pharmaceuticals | -2.53% | +1.05% | +1.58% | -1.53% | -81.58% | 48.41M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ENZY Stock
- Charts Enzymatica AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
